1. Home
  2. KVYO vs AXSM Comparison

KVYO vs AXSM Comparison

Compare KVYO & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Klaviyo Inc. Series A

KVYO

Klaviyo Inc. Series A

HOLD

Current Price

$19.51

Market Cap

5.4B

Sector

N/A

ML Signal

HOLD

Logo Axsome Therapeutics Inc.

AXSM

Axsome Therapeutics Inc.

HOLD

Current Price

$165.22

Market Cap

9.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KVYO
AXSM
Founded
2012
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
9.0B
IPO Year
2023
2015

Fundamental Metrics

Financial Performance
Metric
KVYO
AXSM
Price
$19.51
$165.22
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
22
17
Target Price
$35.55
$209.18
AVG Volume (30 Days)
5.3M
540.1K
Earning Date
01-01-0001
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
35.29
38.56
EPS
N/A
N/A
Revenue
$1,234,019,000.00
N/A
Revenue This Year
$24.47
$61.00
Revenue Next Year
$19.66
$54.38
P/E Ratio
N/A
N/A
Revenue Growth
31.63
N/A
52 Week Low
$15.53
$86.99
52 Week High
$39.66
$191.50

Technical Indicators

Market Signals
Indicator
KVYO
AXSM
Relative Strength Index (RSI) 47.18 36.97
Support Level $15.53 $148.14
Resistance Level $34.18 $191.13
Average True Range (ATR) 1.33 5.64
MACD 0.48 -2.37
Stochastic Oscillator 71.74 19.05

Price Performance

Historical Comparison
KVYO
AXSM

About KVYO Klaviyo Inc. Series A

Klaviyo Inc is a technology company that provides a software-as-a-service (SaaS) platform to enable its customers to send the right messages at the right time across email, short message service, and push notifications, more accurately measure and predict performance, and deploy specific actions and campaigns. The platform combines proprietary data and application layers into one solution with machine learning and artificial intelligence capabilities. It is focused on marketing automation within eCommerce as its first application use case. It generates revenue through the sale of subscriptions to its customers for the use of its platform. Geographically, the company generates the majority of its revenue from the Americas, followed by EMEA and APAC.

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Share on Social Networks: